X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
clinical neurology (5) 5
life sciences (5) 5
middle aged (5) 5
female (4) 4
male (4) 4
neurons and cognition (4) 4
adult (3) 3
disease progression (3) 3
levodopa (3) 3
mutation (3) 3
neurobiology (3) 3
parkinson's disease (3) 3
abridged index medicus (2) 2
aged (2) 2
antiparkinson agents - therapeutic use (2) 2
carpal-tunnel-syndrome (2) 2
clinical trials (2) 2
cognitive science (2) 2
cognitive sciences (2) 2
dopamine (2) 2
dopamine signalling (2) 2
dopaminergic therapy (2) 2
electromyography (2) 2
features (2) 2
france (2) 2
genetics (2) 2
genotype & phenotype (2) 2
motor fluctuations (2) 2
neurology (2) 2
neuropathy (2) 2
neuroscience (2) 2
neurosciences (2) 2
parkinson disease - drug therapy (2) 2
phenotype (2) 2
psychology and behavior (2) 2
retrospective studies (2) 2
trinucleotide repeat expansion - genetics (2) 2
6-hydroxydopamine (1) 1
acid decarboxylase antibodies (1) 1
age of onset (1) 1
aged, 80 and over (1) 1
amantadine (1) 1
amino acids (1) 1
amyloid - genetics (1) 1
amyloid neuropathies, familial - genetics (1) 1
amyloid neuropathies, familial - mortality (1) 1
amyloid neuropathies, familial - physiopathology (1) 1
analysis (1) 1
animals (1) 1
antibodies - blood (1) 1
antioxidants - therapeutic use (1) 1
antiparkinson agents - pharmacology (1) 1
antiparkinsonian agents (1) 1
apraxias - congenital (1) 1
apraxie oculo-motrice (1) 1
arthrite juvénile idiopathique (1) 1
aseptic-meningitis (1) 1
ataxia (1) 1
ataxia - complications (1) 1
ataxia - immunology (1) 1
ataxie (1) 1
atypical parkinsonisms (1) 1
autoantibodies (1) 1
biomedicine (1) 1
biopsy (1) 1
biosensors (1) 1
ca2+ signaling (1) 1
calcium channels - genetics (1) 1
camp signaling (1) 1
cardiomyopathies (1) 1
cardiomyopathies - complications (1) 1
cardiomyopathies - drug therapy (1) 1
cardiomyopathy (1) 1
catechol-o-methyltransferase (1) 1
cell biology (1) 1
clinical trial (1) 1
cogan syndrome - complications (1) 1
complications and side effects (1) 1
denervation (1) 1
diagnosis (1) 1
dopa (1) 1
dopamine - adverse effects (1) 1
dopamine - therapeutic use (1) 1
dopamine receptors (1) 1
double-blind (1) 1
drug development (1) 1
drug metabolism (1) 1
dyskinesias (1) 1
encephalitis (1) 1
encéphalite (1) 1
enseignement (1) 1
erk (1) 1
evolution (1) 1
exons - genetics (1) 1
family health (1) 1
fap (1) 1
friedreich ataxia - drug therapy (1) 1
friedreich ataxia - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurobiology of disease, ISSN 0969-9961, 06/2019, p. 104506
Parkinson's disease (PD) is characterized by severe locomotor deficits due to the disappearance of dopamine (DA) from the dorsal striatum. The development of... 
Life Sciences | Neurons and Cognition | Neurobiology
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 10/2019, Volume 130, pp. 104506 - 104506
Parkinson's disease (PD) is characterized by severe locomotor deficits due to the disappearance of dopamine (DA) from the dorsal striatum. The development of... 
Striatum | Förster resonance energy transfer | 6-hydroxydopamine | Parkinson's disease | cAMP signaling | Mouse | Ca2+ signaling | Two-photon microscopy | Striatal projection neuron | Biosensors | ERK | signaling | Index Medicus
Journal Article
La Revue du praticien, ISSN 0035-2640, 05/2018, Volume 68, Issue 5, p. 515
Therapeutic and pharmacologic perspectives in parkinson's disease. Despite the dopaminergic therapy which improves motor symptoms, there are still a lot of... 
Antiparkinson Agents - therapeutic use | Dyskinesias | Parkinson Disease - drug therapy | Levodopa | Humans | Disease Progression
Journal Article
Neurology, ISSN 0028-3878, 03/2017, Volume 88, Issue 13, pp. e126 - e127
Journal Article
Neurology, ISSN 0028-3878, 03/2017, Volume 88, Issue 13, pp. e126 - e127
Journal Article
Neurology, ISSN 0028-3878, 07/2018, Volume 91, Issue 2, pp. e143 - e152
OBJECTIVETo clearly define transthyretin familial amyloid polyneuropathies (TTR-FAPs) fulfilling definite clinical and electrophysiologic European Federation... 
PERIPHERAL-NERVE | DIAGNOSIS | NEUROPATHY | MANAGEMENT | POEMS SYNDROME | HEREDITARY | POLYRADICULONEUROPATHY | CARPAL-TUNNEL-SYNDROME | FRANCE | CLINICAL NEUROLOGY | FEATURES
Journal Article
Journal Article
Parkinsonism & Related Disorders, ISSN 1353-8020, 07/2019
BACKGROUNDProgressive supranuclear palsy (PSP) is a rare parkinsonian syndrome with a wide spectrum of clinical presentations. Recently, the MDS published... 
Journal Article
Cell and Tissue Research, ISSN 0302-766X, 7/2018, Volume 373, Issue 1, pp. 111 - 135
There is currently no cure for Parkinson’s disease. The symptomatic therapeutic strategy essentially relies on dopamine replacement whose efficacy was... 
Human Genetics | Biomedicine | Dopamine | Proteomics | Dopaminergic therapy | Dopamine signalling | Molecular Medicine | Levodopa | Parkinson’s disease | Drug metabolism | Molecular modelling | Drug development | Dopamine receptors
Journal Article
Joint Bone Spine, ISSN 1297-319X, 10/2018, Volume 85, Issue 5, pp. 643 - 644
Journal Article
JAMA Neurology, ISSN 2168-6149, 09/2016, Volume 73, Issue 9, p. 1105
  Importance: Huntington disease (HD), a prototypic monogenic disease, is caused by an expanded CAG repeat in the HTT gene exceeding 35 units. However, not all... 
Huntingtons disease | Genotype & phenotype | Genes | Genetics | Mutation
Journal Article
Parkinsonism & related disorders, ISSN 1353-8020, 04/2019
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's. The French clinical research network for PD (NS-Park) has... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.